Showing results (111-120 of 224) with videos related to

Sort By:
Pageof 23
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2021
Proposed guidance on cost-avoidance studies in pharmacy practiceAsad E Patanwala, Sujita W Narayan, Curtis E Haas, et al.
Journal of Managed Care & Specialty Pharmacy|June 3, 2025
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a <i>KMT2A</i> translocation in the United StatesIvo Abraham, Pam Martin, Shailja Vaghela, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study)Karen Macdonald, Heidi Brié, Stefaan Vancayzeele, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2009
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) studyHeinz Ludwig, Matti Aapro, Carsten Bokemeyer, et al.
Journal of Geriatric Oncology|September 28, 2013
Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment studyIvo Abraham, Karen MacDonald, Soba Tharmarajah, et al.
International Journal of Nursing Studies|August 17, 2010
Nursing staff attitudes of hip protector use in long-term care, and differences in characteristics between adherent and non-adherent residents: a survey and observational studyKoen Milisen, Joke Coussement, Steven Boonen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 30, 2005
Neglect assessment in urban emergency departments and confirmation by an expert clinical teamTerry Fulmer, Gregory Paveza, Carla Vandeweerd, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2016
Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized TrialsSeongseok Yun, Nicole D Vincelette, Jennifer M Segar, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 12, 2009
Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancerJoanna Van Erps, Matti Aapro, Karen MacDonald, et al.
Journal of the Advanced Practitioner in Oncology|January 18, 2021
Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without <i>BRCA1</i> or <i>BRCA2</i> MutationsAndrew Garcia, Corey Frahm, Joanne M Jeter, et al.
Pageof 23